The Intranuclear distribution of ["^]-estradiol binding sites vas studied in highly purified nuclei Isolated from calf endometrial tissue prelncubated with the labeled hormone. The major part (^5%) of the receptor bound estradiol was found associated with the extranucleolar chromatin; only a negligible amount of [-^Hl-estradiol (^S%) sedimented with the nucleolar fraction. [-%]-estradlol labeled chromatin was then fragmented by Bonlcatian and fractionated by sucrose density gradient sedimentation under different conditions of centrifugation. The vast majority of the [%]-estradiol was invariably found to be associated with a fast sedimenting fraction which contained only 5 to lOjf of the nuclear DNA. The concentration of estradiol receptors (per weight of DNA) in this fraction was 25-to 50-fold higher than that found in the slow sedimenting major chromatin component. Chemical analysis showed this fraction to have a high protein/DNA ratio but no phospholipids were detected.
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IHTRODUCTION
While it is well established that estradlol-178 plays a key role in the regulation of gene expression in the mammalian uterus, details on the mechanism of action of this ovarian hormone are only known to a limited extent. Work from different laboratories has shown that after entering the uterine cells estradiol first binds to a specific cytoplasmic protein, 1 2 called estradiol receptor ' . The hormone receptor complex thus formed appears to undergo a temperature dependent transformation following which the hormonal complex translocates into the nucleus and binds to nuclear "acceptor" sites ' ' . The molecular events by which this hormone-mediated interaction of the receptor with the genome lead to the first measurable modification of gene expression remain to be unveiled.
A first step toward the elucidation of this problem would be the unambiguous identification and isolation of the nuclear acceptor sites involved In the association of the hormone-receptor complex with the genome. Several methods have been reported for the successful fractionation of the chromatin into segments exhibiting different biochemical and physical 35 and 55% of the nuclei of the crude homogenate. The purified nuclei were washed twice with homogenization buffer and either used immediately or quickly frozen in a dry-ice acetone bath and stored at -70°C until required. Subnuclear fractlonation: The procedure described is based on the separation of nucleolar and extranucleolar fractions by the technique of Busch .
Since the concentration of MgCl^ in the first homogenization medium has been reported to be critical for the successful isolation of intact nucle-17 17 oil ' , nuclei to be used in these subnuclear fractionatlon studies were prepared by homogenizing the endometrial cells in the Trls-sucrose buffer containing 10 mM MgClg. The [Tl]-eBtradiol labeled purified nuclei were resuspended in 0.3 1 * M sucrose, 0.05 mM MgCX, and lU mM 2-mercaptoethanol, homogenized gently and sonicated with a Branson sonifier at an output of 60 W for three 15-sec intervals. Periodic microscopic checks under phase contrast showed that more than 95% of the nuclei were disrupted after 1+5 sec of sonicatian. The sonicate was underlaid with 6 ml of 0.88 H sucrose -0.05 mM MgClg and centrifuged at 3,500 rpm for 20 min in a Beckman SWUO rotor. The ensuing pellet consisted mainly of purified nucleoli as evidenced by light microscopic examination after staining with Azure C. The supernatant containing the nuclear sap (nucleoplasm) and the chromatin was made 0.15 M KC1 and centrifuged at 27,000 g for 1*5 min. Receptorbound [Tl]-estradlol was determined in the final chromatin pellet and supernatant (nucleoplasm), as well as in the nucleolar fraction. Preparation of chromatin for fractlonation studies: Purified nuclei were extensively washed in homogenization buffer containing 0.75)5 Triton X-100
to remove the outer nuclear envelope . The pellet was then washed twice with homogenization buffer and resuspended in 10 mM Tris-HCl buffer (pH 8.0) containing 0.15 M KC1. The suspension was then left at 0°C for 90 min under continuous stirring to complete nuclear lysis. The lysed nuclei were sedlmented by centrifugation at 27,000 g for 1*5 min. The final pellet was stirred gently at 0°C in 1 mM Tris-Hd buffer (pH 6.0) at a concentration of 0.25 -1 mg DNA/ml, until the suspension became gelatinous. The chromatin gel was then dlalysed overnight against a large volume of 1 mM Tris-HCl buffer (pH 8.0) care being taken to keep the temperature at 0°C (to minimize dissociation of the [%]-estradiol-receptor complex). The chromatln thus obtained vas a highly homogeneous gel, and vaa fragmented by sanication (total of 2 min in 15-sec pulses at 120 W with 1 min cooling intervals). Following sonication the chromatin vaB clarified toy centrifugation at 12,000 g for 10 min. The supernatant fraction is referred to as "soluble chromatin" and vas used immediately for fractionation studies.
Sucrose density gradient analysis of soluble chromatin: Usually 300 yl of soluble chromatin vas layered on the top of a 6 ml linear gradient of 5 -30J( sucrose containing 1 mM Tris-HCl buffer (pH 8.0). These gradients vere run at 2°C In the *EE 65 ultracentrifuge using the 59587 titanium svingout rotor. Centrifugation conditions vere as indicated under Results. For chemical analysis of chromatin fractions, 2.5 ml of soluble chromatin sample vas fractionated on 55 ml gradients of 5 -305 sucrose by centrifugation at 21,000 rpm for 21 h in the Beckman SW 25.2 rotor. Following centrifugation the gradients vere collected into 30-35 fractions, and absorbance at 260 run vas determined for each fraction on a SAFAS 2000 spectrophotometer. The fractions were then taken for radioactivity counting. Pellets were dissolved in 300 yl (for analytical gradients) or 3 ml (for preparative gradients) of 0.5 M NaOH, and the absorbance at 260 nm determined. A-gn readings for the pellet fractions were corrected for some observed scattering by plotting log A^g.. versus log X, extrapolated for readings in the 380-320 nm portion of the spectrum to 260 nm . In some experiments DNA In the pellet fraction vas also determined by the diphenylamine method and a good correlation was observed between the values obtained and the A-/-, readings. Determination of bound ["^]-estradiol: [Tl]-E8tradiol bound to the uterine receptor vas measured by the hydroxyapatite method described by Erdos 20 et al. . In brief, aliquots of the different labeled preparations vere adsorbed on small hydroxyapatite columns at U°C. Unbound estradlol was eluted by extensive washing vith ice cold buffer. The hydroxyapatite containing the adsorbed estradiol-receptor complexes was then quantitatively transferred into counting vials. Radioactivity was counted in Bray's scintillation solution and quenching corrections were made by the internal standard method. Chemical analysis: Protein concentrations were determined by the biuret 21 method as described by Layne with bovine serum albumin as standard. Nucleic acids were extracted from the nuclear and chromatin pellets •by incubating the uterine slices during 50 min. At this point between 60% and 70% of the receptor bound estradiol of the endometrial homogenate vas obtained in the crude nuclear pellet. The remaining was essentially recovered in the cytosolic fraction. The recovery of bound estradiol in the nuclei purification step closely mirrored the yield of chromosomal material (PHA). We have previously shown that under the incubation conditions used here the major part of the [~Tl]-estradiol present in the nuclear fraction is located intranuclearly and bound to the estradiol receptor, translocated from its cytoplasmic localization after binding the normone.
26 27 28 29 Although there is some controversy concerning the chemical nature of the nuclear acceptor sites, most authors seem to agree on their localization on the chromatin * . However, in the studies published so far reporting the association of the estradiol receptor with the chrc-30 31 matin ' the preparation procedures used did not involve removal of nucleoli and other nuclear components. Such contaminants were therefore present in these chromatin preparations. In order to unambiguously localize the estradiol-receptor complexes within the nucleus, we have made use of a subnuclear fractionation procedure which involves two steps: a) removal of nucleoli from purified and disrupted nuclei, and b) recovery of the chromatin from the post-nucleolar fraction by centrifugation in 0.15 M Kd, leaving the nuclear sap and many membrane fragments in the supernatant. The results of such studies showed that only 8$ of the ["Ti]-estradiol-bound radioactivity was found in the nucleolar pellet along with h% of the initial nuclear DBA. This amount of ERA is similar to values obtained in purified rat liver nucleoli . Most of the receptor-bound [TI]-estradiol (""85%) was recovered in the chromatin fraction, which clearly identifies it as the nuclear component bearing the acceptor sites.
After having demonstrated that no significant amounts of nuclear estradiol-receptor complexes were present in the nucleoli, we followed classical methods for the preparation of chromatin to be used in fractionation studies. Trial experiments prompted us to Introduce some modifications in order to obtain maximal recovery of both bound [TI]-estradiol and DNA in the final soluble chromatin preparation. The final procedure adopted, which is summarized in Table I , deserves some comments. Treatment of purified nuclei with O.75> Triton X-10O in Tris-sucrose buffer resulted in extraction of 15-2OJ of the bound [TJ]-estradiol. Such treatment has been reported to remove the outer layer of the nuclear envelope with Its assoelated perinuclear ribosomes and some but not all of the Inner layer ' . Our results on the chemical composition of intact and Triton X-100 treated nuclei (Table II) wnith show a substantial drop in protein and RNA content after Triton treatment are in line with these findings. Some chromatin DNA was found in the supernatant from the lysis step but since no significant amount of [T!]-e8tradiol-receptor complexes was recovered in this fraction no attempts were made to modify the conditions of nuclear lysis and subsequent centrifugation. After extensive dialysis a homogeneous chromatin gel was obtained which contained 75-85% of the total nuclear DNA and 60-65% of the receptor-bound [ H]-estradiol present in the purified intact nuclei before detergent treatment. Soluble chromatin amenable to biochemical analysis was prepared by fragmenting the chromatin gel by sonication followed by sedimentation of any insoluble debris. Less than 5% of the chromatin DNA and 5-10* of the [Tll-estradlol was sedimented at 12,000 g for 10 nrLn. The supernatant, soluble chromatin, exhibited a typical UV absorption spectrum of highly purified chromatin (Fit,. 2) with A 2 6o
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1.66 and 0.02 respectively. As shown by the data in Table II , the chemical composition of the soluble chromatin further substantiates the purity of the preparations obtained. In addition, the thermal denaturation curve of the sonicated chromatin showed a similar pattern to that previously 2k reported for calf tbymus chromatin . T for the soluble sample was 80°C and hyperchromicity reached 35% • DNA in the gradient (as estimated by the absorbance at 260 run) shows a heterogeneous pattern which can be resolved into three maiTi components. A slowly sedimenting fraction is observed in the upper 1/3 of the gradient containing "^h^% of the chromatin DNA; a faster moving component distributes itself throughout the lower 2/3 of the gradient and comprises UO-50* of the total chromatin; the remaining 5-10* appears In the pellet. These results are consistent with earlier studies concerning the fractionation of calf thymus and mouse myeloma chromatin on sucrose density gradients.
The striking point of this experiment Is that greater than 70* of the [^]-estradiol is found to be associated with the pellet fraction, where only a small part of the chromatin is recovered. Similar results were obtained under other centrlfugation conditions. In Fig. 3B is shown the sedimentation pattern of sonicated chromatin after centrifugation at 50,000 rpm for 1 h. Again most of the ["3]-estradlol sediments in the pellet fraction with less than 10* of the chromatin DNA. In these experiments the radioactivity remaining at the top of the gradient represents primarily free hormone. Centrifugation conditions were found under which Vf5* of the [T]-estradiol was included within the gradient (not shown); Detailed cross-Unking experiments using formaldehyde to be published elsewhere suggest that this association of the estradiol-receptor complex with a flrnnU fraction of the chromatin reflects the in_ vivo location of the nuclear receptor, and Is not the result of the dissociation and reassociation of the protein receptor during sonication and sucrose gradient centri-
fugation.
An unexpected outcome of the studies present herein is that the nuclear acceptor sites for the estradiol-receptor complexes are concentrated in the chromatin fraction which would appear to correspond to the trans- 
